Sepsitron offers a faster and cheaper point-of-care rapid diagnostic device for early detection of blood infections.
Sepsitron offers 50X faster and 10X cheaper point-of-care rapid diagnostic device for early detection of blood infections. Sepsitron's technology is powered by our unique biomarkers, microfluidics, and state-of-the-art electronics to precisely identify multiple pathogens from a single test. Our tests do not require any sample pre-processing and can work with whole blood samples. Sepsitron is funded by the world's best startup accelerators - Entrepreneur First, SOSV Investments, and HAX.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 23, 2020 | Pre-seed | — | 1 | — | — | Detail |
Nov 5, 2019 | Pre-seed | $250K | 1 | — | — | Detail |